eCOA platforms must center the real-world needs of patients, sites, and sponsors...
The gene editing therapy will now be accessible to NHS England patients with bet...
Conduit plans to advance two assets, AZD1656 and AZD5658, into Phase II testing ...
Pharmacosmos will secure its second FDA-approved drug and first oncology therapy...
Coming in response to a rise in teenage overdoses across the US, the Purdue auto...
The contract will see bulk product for Jynneos replenished and additional servic...
Biotech IPOs were up six-fold in Q1 2024 from the previous quarter, but the curr...
Clinical trials are increasingly relying on software-as-a-service (SaaS) provide...
SK pharmteco has entered an MoU with South Korea-based Rznomics for the developm...
The US FDA has granted rare paediatric disease designation for META Pharmaceutic...
Antengene received approval from the Malaysian National Pharmaceutical Regulator...
The China-headquartered CDMO is planning to scale its manufacturing operations, ...
Vocacapsaicin has demonstrated significant pain relief and early opioid cessatio...
The recent success of diabetes and weight loss medications has spurred more inte...
The toxicity of HPAPIs requires careful management and expert CDMOs to assist ac...
In the global pharmaceutical industry, there were 2 private equity deals announc...
